News and Comments

Ariad’s (ARIA) ridaforolimus Brings Hope To Advanced Endometrial Cancer Patients.

  Monday, November 22, 2010

Endometrial cancer is the most common cancer of the female reproductive system. Advanced cases have virtually no effective treatments. Surgery, alone or in combination with radiation, chemotherapy, and/or hormonal therapy are good as initial therapy. In advanced stages, however, surgery has no role to play and chemotherapy has limited, if any, benefit.  More...


Recent Postings


Archive


Tags

AERIE PHARMACEUTICALS Intermune (ITMN) OSI (OSIP) Incyte (INCY) Array Pharmaceuticals (ARRY) Cytokinetics (CYTK) Roche (RHHBY) HALOZYME (HALO) Benlysta (belimumab) Exelixis (EXEL) Mirati Therapeutics (MRTX) ADVENTRIX (ANX) Sanofi (SNA) ARCA (ABIO) Valeant Pharmaceuticals International (VRX) Sanofi-Aventis (SAN) Merck (MRK) Agenus (AGEN) Bristol-Myers Squibb (BMY) galapagos (GLPG) SERES THERAPEUTICS (MCRB) ABBVIE (ABBV) GlaxoSmithKline (GSK) Roche (ROCHE) Human Genome Sciences (HGSI) Sangamo (SGMO) Galena (GALE) Herceptin Onyx (ONXX) ImmunoGen (IMGN) Telaprevir Agenus (AGEN Micromet (MITI) Revlimid (lenolidamide) Biogen Idec (BIIB) NANTKWEST (NK) Dendreon (DNDN) Sequenom (SQNM) Sanofi (SNY) Intercept (ICPT) Abbott Laboratories (ABT) GUARDIAN HEALTH IDERA (IDRA) Sarepta (SRPT) Auspex (ASPX) Theravance (THRX) Multiple Myeloma Anacor (ANAC) JUNO (JUNO) Elan (ELN) NEKTAR (NKTR)) Prosensa (RNA) Amgen (AMGN) BIOMARIN (BMRN) Trastuzumab-DM1 Idenix (IDIX) Prolor Biotech (PBTH) KITE (KITE) Biocryst (BCRX) Genentech Intrexon (XON) Tysabri Seattle Genetics (SGEN) Illumina (ILMN) Ariad (ARIA) Regeneron (REGN) ZALTRAP™ SUNESIS PHARMACEUTICALS (SNSS) VANDA (VNDA) Endometrial Cancer CompuGen (CGEN) Xoma (XOMA) Alnylam (ALNY) Ridaforolimus Anadys (ANDS) C4 Therapeutics Pluristem (PSTI) Aimmune Therapeutics (AIMT) ISIS (ISIS) TOKAI (TKAOI) Inovio (INO) Dynavax (DVAX) Velcade (bortezomib) Gilead (GILD) Vertex (VRTX) Ziofpharm (ZIOP) KERYX (KERX) Zerenex Jazz Pharmaceuticals (JAZZ) SYNTA (SNTA) Rapamune